This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
The New England journal of medicine · 2018
Safety and Side Effects of Rifampin versus Isoniazid in Children.
The New England journal of medicine · 2018
Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.
Thorax · 2010
Latest funding
- $2,945,248
Functional Outcomes, Lung health, and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): a pan-Canadian prospective cohort study
CIHR · 2025 · Co-investigator
- $2,256,752
Utirtisiniq Puvallutulirinirmut arqutigitsugu Inuit Qaujimajatuqangit: Nuisivalialuni Nunavimmiut arqirutisaginnik puvalluniup ammalu namasiangitunut anniasiuriujut Nunavimmi Decolonizing TB Healthcare Through Inuit Qaujimajatuqangit: developing Nunavimmiut-led solutions to the continuing crises of TB and inadequate healthcare in Nunavik
CIHR · 2024 · Co-investigator
- $1,154,425
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
CIHR · 2023 · Principal investigator
4 publications.
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, Obeng Baah J, Marks GB, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Gninafon M, Apriani L, Koesoemadinata RC, Kritski A, Rolla V, Bah B, Camara A, Boakye I, Cook VJ, Goldberg H, Valiquette C, Hornby K, Dion MJ, Li PZ, Hill PC, Schwartzman K, Benedetti A
Safety and Side Effects of Rifampin versus Isoniazid in Children.
Diallo T, Adjobimey M, Ruslami R, Trajman A, Sow O, Obeng Baah J, Marks GB, Long R, Elwood K, Zielinski D, Gninafon M, Wulandari DA, Apriani L, Valiquette C, Fregonese F, Hornby K, Li PZ, Hill PC, Schwartzman K, Benedetti A, Menzies D
Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.
Aspler A, Long R, Trajman A, Dion MJ, Khan K, Schwartzman K, Menzies D
Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial.
Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K
Functional Outcomes, Lung health, and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): a pan-Canadian prospective cohort study
Principal investigators: Campbell, Jonathon; Brode, Sarah K; Johnston, James C; Law, Stephanie
Keywords: Lung Health; Public Health; Quality Of Life; Sequelae; Tuberculosis
Utirtisiniq Puvallutulirinirmut arqutigitsugu Inuit Qaujimajatuqangit: Nuisivalialuni Nunavimmiut arqirutisaginnik puvalluniup ammalu namasiangitunut anniasiuriujut Nunavimmi Decolonizing TB Healthcare Through Inuit Qaujimajatuqangit: developing Nunavimmiut-led solutions to the continuing crises of TB and inadequate healthcare in Nunavik
Principal investigators: Ahmad Khan, Faiz; MacDonald, Natasha I; Sandy, Glenda
Keywords: Community-Based Participatory Action Research; Decolonization; Health Services; Intercultural Communication; Inuit; Nunavik; Self-Determination; Tuberculosis
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina
Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina
Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention
Community Health Workers in Tuberculosis Prevention & Care Services in Nunavik
Principal investigators: Ahmad Khan, Faiz; Andersson, Neil; Fletcher, Christopher; Sandy, Glenda
Keywords: Community Health Worker Training; Community Health Workers; Inuit; Nunavik; Tuberculosis
Preventing tuberculosis in Inuit communitiies: Predicting what may work
Principal investigators: Schwartzman, Kevin; Alvarez, Gonzalo G
Keywords: Cost-Effectiveness Analysis; Decision Analysis; Inuit; Social Determinants; Transmission Model; Tuberculosis
Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease.
Principal investigators: Menzies, Richard
Keywords: Cost Effectiveness Analysis; Drug Resistance; Infectious Disease Modeling; Latent Tuberculosis; Randomized Trial; Systematic Reviews And Meta-Analyses; Tuberculosis; Tuberculosis Prevention; Tuberculosis Treatment
Modeling the impact of interventions for tuberculosis control in Inuit communities
Principal investigators: Schwartzman, Kevin; Alvarez, Gonzalo G
Keywords: Cost-Effectiveness Analysis; Decision Analysis; Inuit; Social Determinants; Tuberculosis
Evaluation of potential biomarkers of successful treatment of latent tuberculosis
Principal investigators: Menzies, Richard
Keywords: Biomarkers; Latent Tuberculosis; Treatment Of Tuberculosis; Tuberculosis; Tuberculosis Prevention
A randomized trial to compare effectiveness of 4 months Rifampin (4 RIF) with 9 months Isoniazid (9 INH) in the prevention of active TB in children: The P4v9 Trial
Principal investigators: Menzies, Richard
Keywords: Child Health; Global Health; Latent Tb Infection; Randomized Trail; Tuberculosis Prevention; Tuberculosis Treatment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Respiratory Epidemiology Unit
- Infectious Diseases
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Kevin Schwartzman
Respiratory Epidemiology Unit
4 shared papers, latest 2018
Andrea Benedetti
Infectious Diseases
3 shared papers, latest 2018
Andrea Benedetti
Faculty
3 shared papers, latest 2018
Rovina Ruslami
Medicine
2 shared papers, latest 2018
Richard Long
Medicine
2 shared papers, latest 2018
Kevin Schwartzman
Faculty
2 shared papers, latest 2018
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.